Bavarian Nordic $BAVA (+0.19%) has received an order for 440.000 doses of its vaccine against Mpox and smallpox from a European 🇪🇺 state, which will 2024 will be delivered in 2024.
By the end of next year, the company can deliver up to ten million doses, of which two million before the end of this year.
The production of the vaccine is already being ramped up before ramped up.